167. Mechanisms of Hormone Action Flashcards
Desensitized and downregulated by phosphorylation or by endocytosis
GPCRs
Present as goiter and tachycardia
Elevated thyroid hormone and normal TSH level
Most common = inactivating mutation in thyroid hormone beta receptor
- beta receptor becomes more active
- other mutations exist
Resistance to thyroid hormone
3 components:
1) Extracellular Ligand Binding domain
2) Single TM domain
3) Intracellular tyrosine kinase catalytic domain
Need to homo-dimerize to activate kinase domains that leads to phosphorylation of many downstream domains and proteins
Receptor tyrosine kinase
Autosomal recessive
Laron Dwarfism
Insensitivity to GH
Reported resistances to diabetes and cancer
Growth Hormone receptor mutations
These receptors act like other tyrosine kinases, but signaling occurs via associate tyrosine kinase associated proteins (Janus Kinase - JAKs)
25 known ligands
Important ones:
- Growth Hormone - needed for growth
- Prolactin - needed for reproduction/lactation
- Leptin - suppresses appetite
Cytokine Activated Receptors
46XY, Genetically male
Phenotype - female
Androgen receptor mutated
Cells can’t sense testosterone
- thus, testosterone is converted to estrogen (reason why they look like females)
Complete androgen insensitivity syndrome
Same structure as receptor tyrosine kinases except these receptors phosphorylate serine/threonine
Two types of receptors:
- Type I - 12 genes
- Type II - 5 genes
Type I and II interact to mediate signaling as dimers
Receptor Serine/Threonine Kinases
Autosomal recessive
- inactivating mutations
Early-onset morbid obesity
Hyperphagia
Leptin receptor mutations
Gain of function mutation of GPCRs
Autoantibodies made to TSH-Receptor
- increase sympathetic andrenergic activity and metabolic rate
Graves’ Disease
100 different types exist
Most sequence/structural variation is in the extracellular domain
Examples of ligands:
- insulin
- epidermal growth factor
- platelet-derived growth factor
Receptor tyrosine kinases
Rickets type 2
- hereditary vitamin D resistance
Presents as:
- Rickets
- Alopecia in most pts
- High levels of 1,25(OH)2VitaminD3
- Variable degrees of hypocalcemia
- Secondary hyperparathyroidism
Mutations in Vitamin D receptor
Made by cleavage of PIP2 by phospholipase C in the non-classical Gq protein GPCR pathway
Ligand for ligand-gated ER bound calcium channels
IP3
Stimulates and inhibit cAMP production by adenylate cyclase respectively
Classical pathway G proteins
Gs and Gi
Nuclear receptor regulate ___ via:
1) ligand-dependent activation
2) ligand-dependent negative regulation
Gene transcription
Example of a genetic defect that affects the tyrosine kinase receptor mechanism
Insulin receptor:
- impaired insulin binding or signaling via mutations in insulin receptor
- –> leads to severe insulin resistance
Most individuals die young (by age of 1yo)
- d/t inability to grow
Donohue syndrome (leprechaunism)
Induces phospholipase C mediated cleavage of PIP2 to IP3 and DAG
(non-classical G protein)
Gq
Often discovered at puberty d/t no menses in a “woman”
Other findings:
- absence of axillary and pubic hair in most cases
- No ovaries
- testes found intra-abdominally and/or in inguinal ring
- No meaningful spermatogenesis as sperm cells need testosterone for initiation
- Vagina often ends as blind pouch
Complete androgen insensitivity syndrome
Loss of function of CaSR (calcium sensing receptor)
- autosomal dominant mutation
- GPCR mutation
Need to distinguish from primary hyperparathyroidism
- concentration of urine calcium will be high in patients with this disease
Low calcium in kidney, high calcium in blood
Familial Hypocalciuric Hypercalcemia
Common features:
- small (less than 1000 daltons)
- lipophilic
- Not directly encoded by the genome, rather synthesized from cholesterol by enzymes or sourced exogenously
Ligands for nuclear receptors
7 TM helices
Coupled intracellularly to heterotrimeric protein - G protein, consisting of the alpha, beta, and gamma subunits
Extracellular domain determines ligand specificity
Intracellular domain determines function via G protein specificity
GPCR
Example of a GPCR disease d/t loss of function of the GPCR mechanism or the vasopressin 2 receptor
Mutation in vasopressin 2 receptor that concentrates urine
- aquaporins can’t get to cell membrane in these patients
Nephrogenic Diabetes Insipidus
5-HT2 serotonergic receptors
Alpha-1 adrenergic receptor
Vasopressin receptors
Angiotensin II receptor Type 1
Membrane receptors that use Gq proteins
Thyroid hormone Estrogen Testosterone Progesterone Aldosterone Cortisol 1,25 - (OH)2 - Vit D3
Classic Nuclear hormones
Gain of function mutations of GPCRs
- hyperfunctional and sporadic
Somatic mutations > autonomous
Hyperfunctioning thyroid nodules (toxic adenomas) leading to hyperthyroidism
Low TSH, high thyroid hormone levels
TSH-receptor mutations
Main action steps:
- Ligand binding
- For most receptors: Dimerization to either homo- or heterodimers
- Binding to Hormone Response Elements (HREs) = receptor specific DNA sequence close to the promotors of genes regulated by this particular receptor
- Optional: binding of co-activators
- Activation or repression of gene transcription
Nuclear receptor activity